Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Gynecology

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791723

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791723

Menopause

PUBLISHED:
PAGES: 181 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Menopause Market to Reach US$22.3 Billion by 2030

The global market for Menopause estimated at US$17.3 Billion in the year 2024, is expected to reach US$22.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Dietary Supplements, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the OTC Pharma Products segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.7 Billion While China is Forecast to Grow at 8.0% CAGR

The Menopause market in the U.S. is estimated at US$4.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.6 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Menopause Care Market - Key Trends & Growth Drivers Summarized

Why Is Menopause Care Gaining More Attention in the Healthcare Industry?

Menopause care is undergoing a major transformation, as awareness about women’s health, hormonal balance, and post-menopausal wellness reaches new heights. Menopause, a natural biological transition that marks the end of menstruation, is associated with a wide range of physical and emotional symptoms, including hot flashes, night sweats, mood swings, osteoporosis, cardiovascular risks, and metabolic changes. Despite affecting millions of women worldwide, menopause care was historically under-discussed and underfunded in the healthcare industry. However, changing attitudes toward women's health, increased advocacy, and technological advancements in hormone therapy and wellness solutions have led to a boom in menopause-focused treatments and holistic care strategies. Pharmaceutical companies, digital health platforms, and wellness brands are now prioritizing menopause-specific solutions, including hormone replacement therapy (HRT), non-hormonal supplements, lifestyle interventions, and AI-driven menopause tracking apps. With longer life expectancy and proactive aging trends, more women are seeking evidence-based menopause care solutions, fueling growth in hormone therapy innovations, telehealth menopause consultations, and personalized wellness programs.

How Are Innovations in Menopause Care Improving Symptom Management?

The menopause care market is evolving rapidly, thanks to advances in hormone therapy, plant-based alternatives, digital health solutions, and AI-powered diagnostics. One of the most significant developments is the refinement of hormone replacement therapy (HRT), including bioidentical hormones and transdermal estrogen patches, which offer safer, more personalized treatments with reduced side effects. The rise of non-hormonal alternatives, such as nutraceuticals, phytoestrogen-based supplements, and adaptogenic herbs, is catering to women seeking natural remedies for menopause symptoms. AI-driven menopause health apps, wearable devices for temperature tracking, and machine-learning-based hormonal analytics are empowering women with real-time insights into symptom patterns, lifestyle adjustments, and treatment recommendations. Additionally, telehealth platforms and virtual menopause clinics are revolutionizing access to specialized care, allowing women to consult endocrinologists, gynecologists, and nutritionists remotely. The development of personalized skincare, vaginal health solutions, and bone density preservation supplements is also expanding menopause care beyond traditional treatment methods, creating a comprehensive ecosystem for aging-related wellness.

Why Is Demand for Menopause Care Increasing Across Diverse Consumer Segments?

The demand for menopause care solutions is surging globally, driven by increased awareness, aging populations, and the destigmatization of menopause discussions. Women in their 40s, 50s, and beyond are now prioritizing proactive health management, leading to increased adoption of supplements, wellness coaching, and integrative menopause treatments. The expansion of corporate wellness programs addressing menopausal health in the workplace is also fueling market growth, as employers recognize the importance of supporting female employees experiencing menopause-related challenges. Additionally, the rising demand for plant-based, cruelty-free, and holistic menopause products reflects a broader trend toward clean-label health solutions. The influence of social media, women’s health influencers, and menopause advocacy groups is further educating women about available treatment options, breaking taboos, and encouraging open discussions about midlife health and aging.

What Is Driving the Growth of the Global Menopause Care Market?

The growth in the menopause care market is driven by rising healthcare investments, increasing demand for personalized treatments, and the integration of AI-driven diagnostics in hormonal health. The expansion of digital health platforms, wearable menopause trackers, and telehealth consultations is making menopause management more accessible and data-driven. The increasing availability of bioidentical hormones, plant-based menopause supplements, and gut-health-focused treatments is catering to diverse consumer preferences. With greater medical research on hormone therapy safety, growing consumer awareness, and the rise of menopause-focused wellness brands, the global menopause care market is positioned for sustained growth, supported by innovative therapies, digital health expansion, and holistic aging solutions.

SCOPE OF STUDY:

The report analyzes the Menopause market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Dietary Supplements, OTC Pharma Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan (an AbbVie company)
  • Amneal Pharmaceuticals LLC
  • Avion Pharmaceuticals, LLC
  • Bayer AG
  • Cipla Inc.
  • Duchesnay USA
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Teva Pharmaceutical Industries Ltd.
  • Theramex
  • TherapeuticsMD, Inc.
  • Viatris Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32089

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Menopause - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness and Openness Around Menopause Health Throws the Spotlight on Women's Midlife Wellness Market
    • Shifting Demographics and Aging Population Spur Demand for Menopause-Focused Therapies and Products
    • Growing Popularity of Holistic and Natural Remedies Strengthens Business Case for Botanical-Based Menopause Solutions
    • Surge in Femtech Innovations Drives Adoption of Digital Menopause Management Tools
    • Increasing Focus on Personalized Healthcare Expands Addressable Market Opportunity for Customized Menopause Treatments
    • Celebrity and Influencer Advocacy Accelerates Demand for Menopause-Friendly Lifestyle Products
    • Integration of AI in Hormonal Health Diagnostics Drives Precision in Menopause Care Solutions
    • Changing Workplace Policies on Women's Health Drives Inclusion of Menopause Benefits in Corporate Wellness Programs
    • Regulatory Push for Recognition of Menopause as a Health Priority Strengthens Funding and Research Opportunities
    • Rapid Proliferation of Direct-to-Consumer (DTC) Brands Spurs Growth of E-commerce Channels for Menopause Products
    • Emerging Clinical Evidence Around Non-Hormonal Alternatives Propels Market for Non-HRT (Hormone Replacement Therapy) Solutions
    • Heightened Investment Activity in Women's Health Tech Ecosystem Expands Innovation Pipeline for Menopause Startups
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Menopause Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dietary Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for OTC Pharma Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for OTC Pharma Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for OTC Pharma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • JAPAN
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • CHINA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • EUROPE
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Menopause by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Menopause by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • FRANCE
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • GERMANY
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Spain 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Russia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Menopause by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Australia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • INDIA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: India 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: South Korea 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Menopause by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Menopause by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Latin America 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Argentina 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Mexico 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Menopause by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Menopause by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Middle East 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Iran 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Israel 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UAE 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • AFRICA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Africa 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!